Cargando…

Structural and Molecular Conservation of Glucagon-Like Peptide-1 and Its Receptor Confers Selective Ligand-Receptor Interaction

Glucagon-like peptide-1 (GLP-1) is a major player in the regulation of glucose homeostasis. It acts on pancreatic beta cells to stimulate insulin secretion and on the brain to inhibit appetite. Thus, it may be a promising therapeutic agent for the treatment of type 2 diabetes mellitus and obesity. D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moon, Mi Jin, Park, Sumi, Kim, Dong-Kyu, Cho, Eun Bee, Hwang, Jong-Ik, Vaudry, Hubert, Seong, Jae Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2012
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500760/ https://www.ncbi.nlm.nih.gov/pubmed/23181056 http://dx.doi.org/10.3389/fendo.2012.00141

Ejemplares similares

A Novel Glucagon-Related Peptide (GCRP) and Its Receptor GCRPR Account for Coevolution of Their Family Members in Vertebrates
por: Park, Cho Rong, et al.
Publicado: (2013)

Does Kisspeptin Belong to the Proposed RF-Amide Peptide Family?
por: Yun, Seongsik, et al.
Publicado: (2014)

Molecular Coevolution of Neuropeptides Gonadotropin-Releasing Hormone and Kisspeptin with their Cognate G Protein-Coupled Receptors
por: Kim, Dong-Kyu, et al.
Publicado: (2012)

Editorial: Trends in Regulatory Peptides
por: Vaudry, Hubert, et al.
Publicado: (2018)

Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications
por: Körner, Meike, et al.
Publicado: (2012)

The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in Pancreatic Beta Cells
por: Marzook, Amaara, et al.
Publicado: (2021)

Activation of PAC1 Receptors in Rat Cerebellar Granule Cells Stimulates Both Calcium Mobilization from Intracellular Stores and Calcium Influx through N-Type Calcium Channels
por: Basille-Dugay, Magali, et al.
Publicado: (2013)

Editorial: A Comparative Survey of the RF-Amide Peptide Superfamily
por: Rousseau, Karine, et al.
Publicado: (2015)

Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes
por: Jia, Yunbo, et al.
Publicado: (2022)

Decreased expression of Glucagon-like peptide-1 receptor and Sodium-glucose co-transporter 2 in patients with proliferative diabetic retinopathy
por: Chen, Hui, et al.
Publicado: (2022)

A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota
por: Zhao, Li, et al.
Publicado: (2018)

It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth
por: Oberle, Megan M., et al.
Publicado: (2019)

Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity
por: Zaffina, Isabella, et al.
Publicado: (2023)

Is Glucagon Receptor Activation the Thermogenic Solution for Treating Obesity?
por: Conceição-Furber, Ellen, et al.
Publicado: (2022)

Utilization of glucagon-like peptide-1 receptor agonists in children and adolescents in China: a real-world study
por: Yan, Yilong, et al.
Publicado: (2023)

Neuropeptide GPCRs in Neuroendocrinology
por: Vaudry, Hubert, et al.
Publicado: (2014)

Comparative Evolutionary Histories of Kisspeptins and Kisspeptin Receptors in Vertebrates Reveal Both Parallel and Divergent Features
por: Pasquier, Jérémy, et al.
Publicado: (2012)

A Combination of Glucagon-Like Peptide-1 Receptor Agonist and Dietary Intervention Could Be a Promising Approach for Obesity Treatment
por: Lee, Chooi Yeng
Publicado: (2021)

A Novel Long-Acting Glucagon-Like Peptide-1 Agonist with Improved Efficacy in Insulin Secretion and β-Cell Growth
por: Kim, Hee Young, et al.
Publicado: (2014)

Galanin Receptors and Ligands
por: Webling, Kristin E. B., et al.
Publicado: (2012)

Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis
por: Wong, Chloe, et al.
Publicado: (2021)

Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
por: Paternoster, Silvano, et al.
Publicado: (2018)

Acute-serum amyloid A and A-SAA-derived peptides as formyl peptide receptor (FPR) 2 ligands
por: Abouelasrar Salama, Sara, et al.
Publicado: (2023)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
por: Seghieri, Marta, et al.
Publicado: (2018)

Editorial: Trends in Neuroendocrinology
por: Vaudry, Hubert
Publicado: (2016)

Impact of short and long exposure to cafeteria diet on food intake and white adipose tissue lipolysis mediated by glucagon-like peptide 1 receptor
por: Mattar, Pamela, et al.
Publicado: (2023)

Exploring the molecular structures that confer ligand selectivity for galanin type II and III receptors
por: Lee, Yoo-Na, et al.
Publicado: (2020)

GRK Inhibition Potentiates Glucagon-Like Peptide-1 Action
por: Lee, Seunghun P., et al.
Publicado: (2021)

Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis
por: Kim, Yoon Ji, et al.
Publicado: (2020)

Comparison of the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Metabolic Associated Fatty Liver Disease: Updated Systematic Review and Meta-Analysis
por: Dai, Yuzhao, et al.
Publicado: (2021)

Can glucagon-like peptide-1 receptor agonists cause acute kidney injury? An analytical study based on post-marketing approval pharmacovigilance data
por: Dong, Shichao, et al.
Publicado: (2022)

Comparison of the efficacy and safety of 10 glucagon-like peptide-1 receptor agonists as add-on to metformin in patients with type 2 diabetes: a systematic review
por: Xie, Zeyu, et al.
Publicado: (2023)

Corrigendum: Impact of short and long exposure to cafeteria diet on food intake and white adipose tissue lipolysis mediated by glucagon-like peptide 1 receptor
por: Mattar, Pamela, et al.
Publicado: (2023)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Editorial: Involvement of Bioactive Peptides in the Control of Cell Survival, Proliferation and Plasticity in Physiological and Pathological Conditions
por: Vaudry, David, et al.
Publicado: (2021)

Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in trout
por: Vanegas, Gilmer, et al.
Publicado: (2015)

Metabolic responses and benefits of glucagon‐like peptide‐1 (GLP‐1) receptor ligands
por: Tanday, Neil, et al.
Publicado: (2021)

Real-world national trends and socio-economic factors preference of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in China
por: Li, Cao, et al.
Publicado: (2022)

Central Control of Feeding Behavior by the Secretin, PACAP, and Glucagon Family of Peptides
por: Sekar, Revathi, et al.
Publicado: (2017)

Research topic: neurosteroids
por: Vaudry, Hubert, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_u74hvjshouum6dksm7fkufcpde